Maryland has awarded more than $520,000 to 18 fire-department groups to run multi-cancer early detection (MCED) screening using 20/20 BioLabs’ OneTest blood assay. The funding, routed through the Maryland Professional and Volunteer Firefighter Innovative Cancer Screening Technologies Grant Program, will support testing of more than 1,400 firefighters starting in April or May. The company said it plans to seek coverage from the U.S. Centers for Medicare and Medicaid Services for OneTest for Cancer, which combines well-established protein tumor marker measurements with machine learning-based artificial intelligence. OneTest is designed to screen for more than a dozen cancer types, including lung, pancreatic, ovarian, and liver cancers, using a CLIA-licensed laboratory in Gaithersburg, Maryland. 20/20 BioLabs is positioning the real-world firefighter dataset as evidence for regulatory engagement with the FDA and payer discussions, while also noting an upcoming OneTest for Longevity launch expected in the first half of 2026.